Bluejay Diagnostics, Inc. 8-K

What Happened

• Bluejay Diagnostics, Inc. (BJDX) announced on February 20, 2026 that it issued a press release providing an update regarding certain warrant and capitalization matters. The disclosure was furnished under Item 7.01 (Regulation FD Disclosure) of a Form 8-K filed the same day (Accession No. 0001213900-26-018638).

Key Details

• Filing date: February 20, 2026.
• Item reported: 7.01 — Regulation FD Disclosure; a press release was furnished as Exhibit 99.1.
• The Form 8-K also includes the standard exhibits filing under Item 9.01 (Exhibit 99.1 and the Inline XBRL cover page).

Why It Matters

• Updates about warrants and capitalization relate to the company’s outstanding securities and share structure; such information can affect potential dilution, shareholder ownership percentages, and market perceptions.
• Retail investors should review the furnished press release (Exhibit 99.1) for the specific terms and numeric details of the warrant and capitalization changes to understand any direct impact on holdings.